CombiMatrix Molecular Diagnostics Receives CLIA Certification

CombiMatrix Molecular Diagnostics has received CLIA certification to operate as a clinical laboratory, the company said last week.

Matt Watson, CEO of CMDX, said his company had been working to establish processes and procedures that would meet quality control and quality assurance standards in line with CLIA since the company was founded in May 2005 (see BAN 5/11/2005).

CMDX is a wholly owned subsidiary of CombiMatrix, which is a unit of Acacia Research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.